Marta Martin Corredera

Marta Martin Corredera has held various roles in the scientific and pharmaceutical industries. In 2021, they were a Project Engineer - PhD Student at Smartimmune and a Junior Project Engineer at Imagine Institute of Genetic Diseases, where they developed T cell progenitors differenciated from Hematopoietic Stem Cells CD34+ from Cord Blood (CB) or mobilized Peripheral Blood (mPB). In 2020, they were a Research and Development Intern at Ciloa SAS. In 2019, they were an Undergraduate Student Researcher at The Open University, where they developed gold nanoparticles (AuNPs) as carriers for Drug Delivery through the Blood-Brain Barrier. In 2018, they were an Industrial Placement Student at Asacpharma, where they were trained on Good Manufacturing Practices and worked on the Acyclovir (R) fabrication process.

Marta Martin Corredera's educational history includes a Doctor of Philosophy - PhD in Biothérapies from Université Paris-Saclay from 2022 to 2025, a Diplôme d'ingénieur in Biotechnologie from ENSTBB Bordeaux INP from 2017 to 2020, a CPGE in Biology, Chemistry, Physics and Geology Sciences from Lycée Chaptal from 2015 to 2017, and a Baccalauréat in Biologie, général from Lycée Français d’Alicante “Pierre Deschamps” from 2000 to 2015. Additionally, they hold certifications from the British Council for an IELTS Test - C1 Level obtained in April 2019, a First Certificate in English: B2 level from the University of Cambridge, and a Selectividad Española from UNED.